04:36 PM EDT, 08/13/2025 (MT Newswires) -- Bobak R. Azamian, Director, President, CEO and Board Chair, on August 11, 2025, sold 6,000 shares in Tarsus Pharmaceuticals ( TARS ) for $300,000. Following the Form 4 filing with the SEC, Azamian has control over a total of 871,741 common shares of the company, with 53,635 shares held directly and 818,106 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000181979025000110/xslF345X05/wk-form4_1755117154.xml